Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IODIXANOL vs IPILIMUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IODIXANOL vs IPILIMUMAB: Safety Overview

Metric IODIXANOL IPILIMUMAB
Total FAERS Reports 2,068 36,528
Deaths Reported 140 8,043
Death Rate 6.8% 22.0%
Hospitalizations 740 17,031
Average Patient Age 61.5 yrs 62.9 yrs
% Female Patients 49.4% 35.4%
FDA Approval Date Aug 29, 1997 N/A
Manufacturer FRESENIUS KABI USA, LLC E.R. Squibb & Sons, L.L.C.
Route INTRAVASCULAR INTRAVENOUS
Marketing Status Prescription Prescription